It is my pleasure to be beginning my second year as editor-in-chief of Contagion®
. I have to admit that I was not entirely sure what I was getting myself into last year, but Contagion®
has exceeded my expectations and I hope it has met yours as well. This year brings some changes to our publication that I am confident will further improve our offerings and increase the value that Contagion®
can bring you.
has benefitted from an expert editorial board since its inception, but this year we are welcoming several more section editors to help cultivate, develop, and edit content for nearly all of the sections of Contagion®
. Our first 2 section editors are continuing with us in 2019. In the Literature is led by Monica Mahoney, PharmD, BCPS-AQ ID, BCIDP, of Beth Israel Deaconess Medical Center, clinical pharmacy coordinator of infectious diseases. Case Studies is led by Sara Schultz, MD, FACP, of Drexel University, an assistant professor and associate program director of the infectious diseases fellowship program. We look forward to their continued contributions.
The 4 new section editors each come to Contagion®
with a wealth of experience in their field. Wendy Bamberg, MD, heads Emerging and Re-Emerging Infections. Dr. Bamberg is a Centers for Disease Control and Prevention-trained medical epidemiologist who directs the Health Care-Associated Infections and Antimicrobial Resistance programs for the Colorado Department of Public Health and Environment. Conan MacDougall, PharmD, MAS, BCPS, BCIDP, a professor at the University of California, San Francisco, leads Stewardship and Prevention. Dr. MacDougall is well known for his work in antimicrobial stewardship and is an author on recent Infectious Diseases Society of America/ Society for Healthcare Epidemiology stewardship guidelines. Jason Schafer, PharmD, MPH, BCPS-AQ ID, BCIDP, AAHIVP, joins us from Thomas Jefferson University, where he is an associate professor and clinical pharmacy specialist in HIV ambulatory care. Dr. Schafer is leading the HIV/AIDS section. Finally, Ryan Shields, PharmD, MS, an associate professor at the University of Pittsburgh, is leading Multidrug-Resistant Infections. Dr. Shields is well known for his work with multiple facets of resistant infections, notably for recent studies on carbapenem-resistant Enterobacteriaceae.
This is the first issue with all 6 section editors contributing their expertise, and I am looking forward to hearing more of the suggestions and seeing where they take our publication. For this issue, our feature article is “Staying Ahead of the Curve: Implementation of AUC-Guided Vancomycin Dosing
” by Jamie Kisgen, PharmD, BCPS-AQ ID, and Megan Seddon, PharmD. Drs. Kisgen and Seddon take us through the latest chapter in the continuing saga of vancomycin dosing, one of the current hot topics in infectious diseases pharmacotherapy.
Happy New Year, and enjoy this issue of Contagion®
Dr. Gallagher is a clinical professor at Temple University School of Pharmacy and clinical pharmacy specialist in infectious diseases at Temple University Hospital, both in Philadelphia, Pennsylvania. He is also the director of the PGY2 Residency in Infectious Diseases Pharmacy at Temple.